India to Vietnam: Amphotericin Export Trade Route
India has recorded 33 verified shipments of Amphotericin exported to Vietnam, representing a combined trade value of $4.7M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $142.1K USD. The leading Indian exporter is BHARAT SERUMS AND VACCINES LIMITED, which accounts for 69% of total export value with 19 shipments worth $3.2M USD. On the buying side, MAXXCARE COMPANY LIMITED is the largest importer in Vietnam with $1.7M USD in purchases. The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, BHARAT SERUMS AND VACCINES LIMITED , LYKA LABS LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Vietnam Amphotericin corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $4.7M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's amphotericin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $142.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 16.6%, placing it at rank #12 among India's top amphotericin export destinations globally.
On the import side, key buyers of Indian amphotericin in Vietnam include MAXXCARE COMPANY LIMITED, MAXXCARE COMPANY LIMITED , MAXXCARE COMPANY LIMITED, and 6 others. MAXXCARE COMPANY LIMITED is the single largest importer with 12 shipments valued at $1.7M USD.
